US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Transgene SA (0OCQ) 銘柄情報

Transgene SA (0OCQ)

3.04

0.00

(0.00%)

終了 7月4日 12:30AM

Transgene SA (0OCQ) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.04

( - )

買値

3.04

売値

3.04

出来高

600

0.00 日の範囲 0.00

3.04 52 週間の範囲 3.04

時価総額

前日終値

3.04

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

41,661 €

発行済株式数

273,882,230

配当利回り

PER

-2.81

1 株当たり利益 (EPS)

-0.26

歳入

7.21M

純利益

-37.52M

Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of head and neck cancers; TG4001, a therapeutic v... Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial. It has strategic collaboration agreements with NEC Corporation and NEC Bio, BioInvent, Merck & Co., Inc., Oxford Biomedica, Stamford, SillaJen, and ProBioGen. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.transgene.com

本社

Illkirch-graffenstaden, France

設立

1979

Transgene SA is listed in the sector of the ロンドン証券取引所 with ticker 0OCQ. The last closing price for Transgene was 3.04 €. Over the last year, Transgene shares have traded in a share price range of 3.04 € to 3.04 €.

Transgene currently has 273,882,230 shares in issue. The market capitalisation of Transgene is 832.60 € million. Transgene has a price to earnings ratio (PE ratio) of -2.81.

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate...

Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA

Transgene présente des données précliniques de son vaccin innovant contre le mpox produit sur lignée cellulaire, TG-MVA Basé sur un vecteur viral...

Transgene étend sa plateforme myvac® avec TG4070, un vaccin thérapeutique individualisé dans le cancer du poumon non à petites cellules

Transgene étend sa plateforme myvac® avec TG4070, un vaccin thérapeutique individualisé dans le cancer du poumon non à petites cellules Associant...

Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine

Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine Combining cutting-edge...

Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases TG-MVA builds...

Transgene présente des résultats précliniques avec TG-MVA, un nouveau vaccin prophylactique contre la variole du singe (mpox), au Congrès mondial sur les maladies infectieuses

Transgene présente des résultats précliniques avec TG-MVA, un nouveau vaccin prophylactique contre la variole du singe (mpox), au Congrès mondial...

Transgene’s Combined General Meeting of May 22, 2026

Transgene’s Combined General Meeting of May 22, 2026 Strasbourg, France, May 22, 2026, 5:45 p.m. CET – The Combined Ordinary and Extraordinary...

Assemblée Générale Mixte de Transgene du 22 mai 2026

Assemblée Générale Mixte de Transgene du 22 mai 2026 Strasbourg, France, le 22 mai 2026, 17 h 45 – L’Assemblée Générale Mixte (ordinaire et...

Mise à disposition des documents préparatoires à l'Assemblée générale du 22 mai 2026

Mise à disposition des documents préparatoires à l'Assemblée générale du 22 mai 2026 Strasbourg, France, le 4 mai 2026, 17 h 45 – Transgene...

Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026

Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026 Strasbourg, France, May 4, 2026, 5:45 p.m. CET – Transgene...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	3.04	3.04	3.04	913	3.04	DE
52	0	0	3.04	3.04	3.04	1503	3.04	DE
156	0	0	3.04	3.04	3.04	537	3.04	DE
260	0	0	3.04	3.04	3.04	749	3.04	DE

0OCQ - Frequently Asked Questions (FAQ)

What is the current Transgene SA share price?

The current share price of Transgene SA is 3.04 €

How many Transgene SA shares are in issue?

Transgene SA has 273,882,230 shares in issue

What is the market cap of Transgene SA?

The market capitalisation of Transgene SA is EUR 832.6M

What is the 1 year trading range for Transgene SA share price?

Transgene SA has traded in the range of 3.04 € to 3.04 € during the past year

What is the PE ratio of Transgene SA?

The price to earnings ratio of Transgene SA is -2.81

What is the cash to sales ratio of Transgene SA?

The cash to sales ratio of Transgene SA is 27.77

What is the registered address of Transgene SA?

The registered address for Transgene SA is 400, boulevard Gonthier d’Andernach, Illkirch-Graffenstaden, Alsace, 67405

What is the Transgene SA website address?

The website address for Transgene SA is www.transgene.com

chen1992

chen1992 5分前

Breadcrumbs can absolutely come. If they even hint at a possibility of going public, there ya go.

gladeshawk

gladeshawk 5分前

Bitcoin rally started this week, imho. IF it has started it could be "explosive". TWT. HAWK

PutzMueler

PutzMueler 5分前

I asked AI

“what would an underground mine with an above ground processing facility need 6 natural gas engines and 1 natural gas boiler for?”

***************
Such a configuration is a classic Combined Heat and Power (CHP) and Central Heating syst

cowtown jay

cowtown jay 5分前

Doc 389 is the latest docket item filed in Humanigen's bankruptcy case, as I reported and linked yesterday. Here's the link again.

https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1233160&projectCode=HUM&docketNumber=389&source=DM

If I am wrong about

delerious1

delerious1 5分前

Yikes HG-ca is down 11% today

cashclan

cashclan 6分前

Hopefully

They leave the SS alone for a while

I've seen larger SS go into the $100's of dollars ...

https://peakcartcorp.com/

Forensics888

Forensics888 6分前

And those involved in the self dealing and “negotiations” need to be investigated for possible bribery and kickbacks.

No one in their right mind would agree to such terms unless there was something in it for them.

Fannie and Freddie represent the FRAUD of the CENTURY- T

gladeshawk

gladeshawk 7分前

We may have seen the start of an "explosive" rally this week. Next week it should continue. I believe LMFA will benefit big time. TWT. HAWK

gladeshawk

gladeshawk 8分前

Bitcoin(s) rally should continue next week. In fact I think it could be "explosive" to the upside. TWT. HAWK

CryptoRain

CryptoRain 8分前

Enjoy it while you can. Your run is about over

02opida

02opida 9分前

02opida

02opida 9分前

02opida

02opida 10分前

02opida

02opida 10分前

02opida

02opida 10分前

02opida

02opida 10分前

02opida

02opida 10分前

02opida

02opida 11分前

02opida

02opida 11分前

Renorocker

Renorocker 11分前

Would need the SP to get at least .05 to make a RS any sense.
From 7B OS to 700M at a 10/1 split would be good OS wise but would only be .50 share price and we would need $2-$4 sp to get to NAZDAQ. Growing organically from here is where Emil & co I would hope is the route we go.

02opida

02opida 11分前

02opida

02opida 11分前

02opida

02opida 11分前

02opida

02opida 11分前

02opida

02opida 12分前

United Therapeutics

CDC4%13JUN2033 CDC4%13JU...

Tenaris SA Luxembourg (PK)

Blackham Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。